- Home
- INHD vs TENX Comparison
INHD vs TENX Comparison
Compare INHD & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INHD
- TENX
- Stock Information
- Founded
- INHD 2019
- TENX 1967
- Country
- INHD United States
- TENX United States
- Employees
- INHD N/A
- TENX N/A
- Industry
- INHD
- TENX Biotechnology: Pharmaceutical Preparations
- Sector
- INHD
- TENX Health Care
- Exchange
- INHD Nasdaq
- TENX Nasdaq
- Market Cap
- INHD 12.1M
- TENX 11.4M
- IPO Year
- INHD 2023
- TENX N/A
- Fundamental
- Price
- INHD $4.19
- TENX $4.94
- Analyst Decision
- INHD
- TENX Strong Buy
- Analyst Count
- INHD 0
- TENX 4
- Target Price
- INHD N/A
- TENX $20.67
- AVG Volume (30 Days)
- INHD 147.8K
- TENX 96.4K
- Earning Date
- INHD 11-26-2024
- TENX 11-13-2024
- Dividend Yield
- INHD N/A
- TENX N/A
- EPS Growth
- INHD N/A
- TENX N/A
- EPS
- INHD N/A
- TENX N/A
- Revenue
- INHD $693,570.00
- TENX N/A
- Revenue This Year
- INHD N/A
- TENX N/A
- Revenue Next Year
- INHD N/A
- TENX N/A
- P/E Ratio
- INHD N/A
- TENX N/A
- Revenue Growth
- INHD N/A
- TENX N/A
- 52 Week Low
- INHD $3.00
- TENX $2.77
- 52 Week High
- INHD $192.10
- TENX $41.92
- Technical
- Relative Strength Index (RSI)
- INHD 45.67
- TENX 64.74
- Support Level
- INHD $3.00
- TENX $4.50
- Resistance Level
- INHD $8.99
- TENX $5.09
- Average True Range (ATR)
- INHD 0.97
- TENX 0.29
- MACD
- INHD 0.05
- TENX 0.01
- Stochastic Oscillator
- INHD 20.54
- TENX 73.56
About INHD Inno Holdings Inc.
Inno Holdings Inc is a building technology company with a mission to transform the construction industry with its proprietary cold-formed steel-framing technology and other innovations. It is a manufacturer of cold-formed-steel members and prefabricated homes. It offers a full range of services required to transform raw materials into precise steel framing products and prefabricated homes. The company sells these finished products either to businesses or directly to customers. The finished products and cold-formed-steel members are used in a variety of building types, including residential, commercial, industrial and infrastructure.
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.